3 ms·
There was also no control group, which is a fatal flaw in any depression related study. If you're not aware: Depression studies have a very high placebo respon
by Aurornis 3y ago
There was also no control group, which is a fatal flaw in any depression related study.
If you're not aware: Depression studies have a very high placebo response rate. It's often hard to get new antidepressants to demonstrate improvements in studies not because the patients don't get better, but because the placebo group improves so much that the difference between the groups is small.
This doesn't mean that antidepressants are placebo, it just means that if you take depressed people and tell them they're going to get better, then give them a lot of attention and activity from clinicians, they start to improve.
This study definitely needs a control group, as the patients went all the way to Mexico on a small vacation to receive the drug. I guarantee that if you take a cohort of depressed patients, send them to Mexico for a short vacation and hand them a placebo pill that you tell them is an antidepressant, many of them will improve substantially on various measures upon return.
This is why placebo control groups are critical for any depression study. I don't think it's a coincidence that so many of these psychedelics-for-depression studies omit control groups. Including a control group increases the cost, but it also is guaranteed to reduce the "wow factor" of a depression study. Therefore, they get omitted any time someone wants to make an antidepressant look effective.
If this was a study for a new SSRI that didn't have a control group, people would be tearing it apart. For some reason people love stories about psychedelics doing magical things, though, so a lot of people are willing to overlook the most glaring fault of this study.
- BobaFloutist 3y agoPTSD is a dramatically different disorder to MDD though, no? It has pretty acute effects, and I don't know, but I would imagine it's less susceptible to placebo. Not to say this trial is any higher quality than it is, or that your sidebar on MDD wasn't interesting, but I'm not sure it's that effective of a comparison.
- worik 3y agoYes. But psychedelic studies are impossible with double blind It is important to be rigorous in your study, but cannot expect too much Psychedelic therapies are not like antibiotic therapies, they interact in complex and confounding ways with set and setting
- elmomle 3y agoIt is not the medicine by itself but the whole experience around it. Practitioners feel deeply that the medicine is an essential part of the experience. This raises the question, which I think is a very good one, of what a valid control would even look like.